Kim A. Rivers - 25 Jul 2023 Form 4 Insider Report for Trulieve Cannabis Corp. (TCNNF)

Signature
Eric Powers, Attorney-in-Fact
Issuer symbol
TCNNF
Transactions as of
25 Jul 2023
Net transactions value
$0
Form type
4
Filing time
27 Jul 2023, 21:42:57 UTC
Previous filing
16 Mar 2023
Next filing
16 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCNNF Subordinate Voting Shares Award $0 +195,552 +7.8% $0.000000 2,691,238 25 Jul 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCNNF Stock Option (Right to Buy) Award $0 +435,154 $0.000000 435,154 25 Jul 2023 Subordinate Voting Shares 435,154 $6.52 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. 50% of the RSUs will vest on December 1, 2024, and the remaining 50% of the RSUs will vest on December 1, 2025.
F2 The reporting person also holds the following securities of the issuer: (i) 159,867 aggregate Multiple Voting Shares held directly, (ii) 9,867 Multiple Voting Shares held by Traunch IV LLC ("Traunch IV"), over which the reporting person may be deemed to exercise voting and investment control, and (iii) a stock option to acquire 356,867 Subordinate Voting Shares exercisable as of May 1, 2023 held directly. Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis (or into an aggregate of 16,973,400 Subordinate Voting Shares). The reporting person disclaims beneficial ownership of the Multiple Voting Shares (and the Subordinate Voting Shares into which they are convertible) held by Traunch IV, except to the extent of her pecuniary interest therein.
F3 The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2023, one-third vesting on December 1, 2024, and one-third vesting on December 1, 2025.